To carry out development for a drug candidate small molecule inhibitor against chikungunya virus, an alphavirus that causes debilitating and sometimes life-threatening disease in humans.
Active Definitive Contract Awarded Last action
- Contract number
- 75N93023C00002
- Awardee
-
Oregon Health & Science University UEI NPSNT86JKN51
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,422,654
Award facts
- Opportunity
-
- 2022 NIAID Omnibus Broad Agency Announcement Pre-Solicitation · BAA20221 · Posted Jan 4, 2022
- Contract value 54% obligated
-
- $7,422,654.00 Current, with exercised options
- $13,809,006.00 Potential, with all options
- Completion date 88% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 10 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Portland, OR 97239, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $2,726,302 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $4,696,352 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $13.8 million definitive contract to Oregon Health & Science University for development of a small molecule inhibitor against Chikungunya virus on November 1, 2022, with performance through May 31, 2027, under cost-plus-fixed-fee pricing.
The originating solicitation, posted January 4, 2022, was a Broad Agency Announcement from NIAID seeking proposals for vaccine candidates, therapeutics, and diagnostics for biodefense, antimicrobial resistant infections, and emerging infectious diseases. The specific scope targets development of a novel 2-pyrimidone (SRI-42718) as a potent inhibitor of Chikungya virus infection and disease. Place of performance is Portland, Oregon.
Service Contract Inventory reporting shows actual government-invoiced labor of $548 thousand in FY2023 (1.6 FTEs, 3,322 hours), $2.4 million in FY2024 (7.0 FTEs, 14,560 hours), and $1.4 million in FY2025 (2.6 FTEs, 5,472 hours), with derived hourly rates of $165.09/hr (FY2023), $166.45/hr (FY2024), and $253.25/hr (FY2025) reflecting an upward trend. In FY2025, Oregon Health & Science University reported 67% of contractor hours subcontracted, with five named subcontractors including Sri International, University of Alabama at Birmingham, Southern Research Institute, University of North Carolina at Chapel Hill, and University of Colorado-Denver.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Element Materials Technology Santa Clara Inc. | $187,000 | |
| University Of Alabama At Birmingham | $18,000 | |
| Sri International | $390,231 | |
| Southern Research Institute | $345,915 | |
| University Of North Carolina At Chapel Hill | $811,407 | |
| The Regents Of The University Of Colorado | $447,867 |
Quick answers
Who was awarded contract 75N93023C00002?
75N93023C00002 was awarded to Oregon Health & Science University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on November 1, 2022.
How much is contract 75N93023C00002 worth?
The government has obligated $7,422,654 on 75N93023C00002. Its potential value, with all options, is $13,809,006.
Was contract 75N93023C00002 competed?
The extent of competition for 75N93023C00002 was full and open competition. The government received 10 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award